Will New Trial Solution Data Spark a Rally for this Dual-Listed Gen AI Clinical Trial Leader?
February 29 2024 - 10:00AM
AllPennyStocks.com
Parkinson’s disease is a complex and debilitating disease with a
need for novel treatment options. This firm’s goal is to advance
its understanding of the biological markers and...
To read the full story on AllPennyStocks.com, click
here.
NetraMark (CSE:AIAI)
Historical Stock Chart
From Dec 2024 to Jan 2025
NetraMark (CSE:AIAI)
Historical Stock Chart
From Jan 2024 to Jan 2025
